Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Schultz

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproductionJ P Bader, J B McMahon, R J Schultz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideR W Buckheit, T L Kinjerski, V Fliakas-Boltz, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproductionJ P Bader, J B McMahon, R J Schultz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideR W Buckheit, T L Kinjerski, V Fliakas-Boltz, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitorJ B McMahon, R W Buckheit, R J Gulakowski, et al.
Pageof 6